Louse-borne relapsing fever is caused by the spirochete bacterium Borrelia recurrentis, which is transmitted by body lice (not head lice). The disease was first described by Hippocrates (460-370 BC).
InflaRx intends to engage with EMA regarding both vilobelimab and izicopan to evaluate the regulatory path to approval in ANCA-associated vasculitis (AAV) The Company is assessing the most efficient ...
Sanofi provides update on MOBILIZE phase 3 study of riliprubart in chronic inflammatory demyelinating polyneuropathy Paris, June 10, 2026. Sanofi today announced that the riliprubart MOBILIZE phase ...
Sanofi (NASDAQ:SNY) said on Wednesday that it has decided to discontinue the phase 3 MOBILIZE trial evaluating riliprubart in patients with chronic inflammatory demyelinating polyneuropathy (CIDP) who ...
Morning Overview on MSN
The first US trials of gene-edited pig kidneys in patients are set to begin
Patients with end-stage kidney disease who have spent years on transplant waitlists now face a new clinical reality: two ...
Priority review for cemdisiran addresses adult anti-AChR–positive gMG, leveraging a priority review voucher and aligning US and EU regulatory timelines through 2027. RNAi-mediated C5 suppression ...
The concept of trained immunity has redefined innate immune responses as adaptable, durable, and context dependent. Natural killer (NK) cells, traditionally ...
A defense system that cannot distinguish friend from stranger eventually harms the organization it is supposed to protect.
Researchers at Hospital for Special Surgery (HSS) have uncovered a critical link between the immune system in early life and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results